Citation

82 FR 26494

Canonical document for this Federal Register citation.

Developing Rabies Monoclonal Antibody Products as a Component of Rabies Post-Exposure Prophylaxis; Public Workshop; Request for Comments Wednesday, June 7, 2017 82 FR 26494